Literature DB >> 15312868

Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.

Khuram W Chaudhary1, Eric I Rossman, Valentino Piacentino, Agnes Kenessey, Chris Weber, John P Gaughan, Kaie Ojamaa, Irwin Klein, Donald M Bers, Steven R Houser, Kenneth B Margulies.   

Abstract

OBJECTIVES: The objective of the present study was to determine whether improved contractility after left ventricular assist device (LVAD) support reflects altered myocyte calcium cycling and changes in calcium-handling proteins.
BACKGROUND: Previous reports demonstrate that LVAD support induces sustained unloading of the heart with regression of pathologic hypertrophy and improvements in contractile performance.
METHODS: In the human myocardium of subjects with heart failure (HF), with non-failing hearts (NF), and with LVAD-supported failing hearts (HF-LVAD), intracellular calcium ([Ca(2+)](i)) transients were measured in isolated myocytes at 0.5 Hz, and frequency-dependent force generation was measured in multicellular preparations (trabeculae). Abundance of sarcoplasmic reticulum Ca(2+) adenosine triphosphatase (SERCA), Na(+)/Ca(2+) exchanger (NCX), and phospholamban was assessed by Western analysis.
RESULTS: Compared with NF myocytes, HF myocytes exhibited a slowed terminal decay of the Ca(2+) transient (DT(terminal), 376 +/- 18 ms vs. 270 +/- 21 ms, HF vs. NF, p < 0.0008), and HF-LVAD myocytes exhibited a DT(terminal) that was much shorter than that observed in HF myocytes (278 +/- 10 ms, HF vs. HF-LVAD, p < 0.0001). Trabeculae from HF showed a negative force-frequency relationship, compared with a positive relationship in NF, whereas a neutral relationship was observed in HF-LVAD. Although decreased SERCA abundance in HF was not altered by LVAD support, improvements in [Ca(2+)](i) transients and frequency-dependent contractile function were associated with a significant decrease in NCX abundance and activity from HF to HF-LVAD.
CONCLUSIONS: Improvement in rate-dependent contractility in LVAD-supported failing human hearts is associated with a faster decay of the myocyte calcium transient. These improvements reflect decreases in NCX abundance and transport capacity without significant changes in SERCA after LVAD support. Our results suggest that reverse remodeling may involve selective, rather than global, normalization of the pathologic patterns associated with the failing heart.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2004        PMID: 15312868     DOI: 10.1016/j.jacc.2004.05.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 2.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 3.  Molecular and cellular basis of viable dysfunctional myocardium.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Javed Butler; Mihai Gheorghiade; Hossein Ardehali
Journal:  Circ Heart Fail       Date:  2014-07       Impact factor: 8.790

Review 4.  Taking pressure off the heart: the ins and outs of atrophic remodelling.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2011-02-25       Impact factor: 10.787

5.  Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

Authors:  Marc A Simon; Brian A Primack; Jeffrey Teuteberg; Robert L Kormos; Christian Bermudez; Yoshiya Toyoda; Hemal Shah; John Gorcsan; Dennis M McNamara
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

6.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

7.  c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia.

Authors:  Khadija Rafiq; Mikhail A Kolpakov; Rachid Seqqat; Jianfen Guo; Xinji Guo; Zhao Qi; Daohai Yu; Bhopal Mohapatra; Neha Zutshi; Wei An; Hamid Band; Archana Sanjay; Steven R Houser; Abdelkarim Sabri
Journal:  Circulation       Date:  2014-02-28       Impact factor: 29.690

Review 8.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

9.  Ventricular arrhythmias after left ventricular assist device implantation.

Authors:  Marwan Refaat; Elie Chemaly; Djamel Lebeche; Judith K Gwathmey; Roger J Hajjar
Journal:  Pacing Clin Electrophysiol       Date:  2008-10       Impact factor: 1.976

10.  Short-term mechanical unloading with left ventricular assist devices after acute myocardial infarction conserves calcium cycling and improves heart function.

Authors:  Xufeng Wei; Tieluo Li; Brian Hagen; Pei Zhang; Pablo G Sanchez; Katrina Williams; Shuying Li; Giacomo Bianchi; Ho Sung Son; Changfu Wu; Christopher DeFilippi; Kai Xu; William J Lederer; Zhongjun J Wu; Bartley P Griffith
Journal:  JACC Cardiovasc Interv       Date:  2013-03-20       Impact factor: 11.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.